HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Yuko Kinashi Selected Research

TX 2100

6/2006The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy.
2/2006Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Yuko Kinashi Research Topics

Disease

33Neoplasms (Cancer)
01/2014 - 12/2002
10Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2010 - 12/2002
6Anoxia (Hypoxia)
02/2010 - 10/2004
4Mesothelioma
07/2009 - 12/2006
4Fever (Fevers)
02/2007 - 01/2003
2Glioblastoma (Glioblastoma Multiforme)
01/2015 - 01/2011
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2014 - 05/2007
2Brain Neoplasms (Brain Tumor)
05/2007 - 02/2006
1Heart Diseases (Heart Disease)
08/2014
1Fanconi Anemia (Fanconi's Anemia)
01/2011
1Glioma (Gliomas)
05/2009
1Melanoma (Melanoma, Malignant)
01/2009
1Neoplasm Metastasis (Metastasis)
01/2009
1Thyroid Neoplasms (Thyroid Cancer)
05/2007
1Hepatocellular Carcinoma (Hepatoma)
05/2007

Drug/Important Bio-Agent (IBA)

20Bromodeoxyuridine (BrdU)IBA
10/2010 - 12/2002
8SASIBA
01/2010 - 12/2002
8Cytochalasin BIBA
03/2006 - 01/2003
8SuspensionsIBA
03/2006 - 12/2002
5mercaptoundecahydrododecaborate (borocaptate sodium)IBA
11/2009 - 12/2002
4Niacinamide (Nicotinamide)FDA LinkGeneric
02/2010 - 10/2004
4tirapazamine (SR 4233)IBA
02/2007 - 01/2003
3CarbonIBA
02/2010 - 01/2008
3Ethiodized Oil (Ethiodol)FDA Link
11/2004 - 03/2004
2BoronIBA
01/2011 - 05/2004
2MisonidazoleIBA
02/2010 - 03/2006
2Cisplatin (Platino)FDA LinkGeneric
01/2010 - 01/2003
2Liposomes (Liposome)IBA
05/2009 - 12/2006
2wortmanninIBA
12/2007 - 05/2003
2N-acetylcochinol-O-phosphateIBA
01/2007 - 08/2005
2TX 2100IBA
06/2006 - 02/2006
23-amino-2-quinoxalinecarbonitrileIBA
02/2006 - 08/2005
2SodiumIBA
11/2004 - 05/2004
1Proteins (Proteins, Gene)IBA
08/2014
1Advanced Glycosylation End ProductsIBA
08/2014
1DNA (Deoxyribonucleic Acid)IBA
01/2011
1temozolomide (Temodar)FDA LinkGeneric
01/2011
1Alkylating AgentsIBA
01/2011
1NimustineIBA
01/2011
1pimonidazoleIBA
10/2010
1Methenamine (Hexamine)IBA
01/2010
1Prostaglandins A (PGA)IBA
11/2009
1Transferrin (beta 2 Transferrin)IBA
12/2006
1Boron CompoundsIBA
12/2006
1NimorazoleIBA
03/2006
1CytotoxinsIBA
08/2005
1Carbon MonoxideIBA
08/2005
1degradable starch microspheresIBA
11/2004
1OxygenIBA
10/2004
1carbogenIBA
10/2004
1TX-2060IBA
09/2004
1Paclitaxel (Taxol)FDA LinkGeneric
01/2003
1CadmiumIBA
12/2002

Therapy/Procedure

17Boron Neutron Capture Therapy
01/2015 - 03/2004
5Radiotherapy
01/2009 - 03/2004
1Drug Therapy (Chemotherapy)
01/2011
1Synchrotrons
05/2009
1Induced Hyperthermia (Thermotherapy)
01/2009
1Intraperitoneal Injections
01/2003
1Oral Administration
01/2003